Tearsheet

RCM Technologies (RCMT)

Market Price (12/24/2025): $20.28 | Market Cap: $150.3 Mil
Sector: Industrials | Industry: Industrial Conglomerates

RCM Technologies (RCMT)

Market Price (12/24/2025): $20.28
Market Cap: $150.3 Mil
Sector: Industrials
Industry: Industrial Conglomerates

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.7%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.5%	Weak multi-year price returns 2Y Excs Rtn is -74%, 3Y Excs Rtn is -39%	Key risks RCMT key risks include [1] its heavy concentration of revenue from a limited number of customers and specific business segments, Show more.
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 14%
2	Low stock price volatility Vol 12M is 42%
3	Megatrend and thematic drivers Megatrends include Cloud Computing, Cybersecurity, and Artificial Intelligence. Themes include Hybrid Cloud Solutions, Show more.

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.7%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.5%
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 14%
2	Low stock price volatility Vol 12M is 42%
3	Megatrend and thematic drivers Megatrends include Cloud Computing, Cybersecurity, and Artificial Intelligence. Themes include Hybrid Cloud Solutions, Show more.
4	Weak multi-year price returns 2Y Excs Rtn is -74%, 3Y Excs Rtn is -39%
5	Key risks RCMT key risks include [1] its heavy concentration of revenue from a limited number of customers and specific business segments, Show more.

Valuation, Metrics & Events

	12/24/25	2024	2023	2022	2021
Share Price CYE	$20.28	$22.16	$29.04	$12.34	$7.12
Market Cap CYE ($ Mil)	150.3	168.4	227.3	119.6	78.1
Total Debt ($ Mil)	37.9	42.2	34.0	13.8	18.2
Total Cash ($ Mil)	1.3	4.7	6.3	0.3	0.2
Enterprise Value ($ Mil)	186.9	210.6	261.3	133.4	96.3
Valuation Ratios
P/S TTM	0.5	0.6	0.9	0.4	0.4
P/EBIT TTM	6.5	7.7	10.2	4.3	5.5
P/E TTM	11.5	12.9	14.3	5.9	7.2
P/FCF TTM	42.9	47.7	25.3	4.5	226.4
Sector Ratios
P/S TTM (Sector)	1.7	1.5	1.4	1.1	1.6
P/EBIT TTM (Sector)	12.9	11.9	11.2	9.1	12.3
P/E TTM (Sector)	17.1	16.5	15.4	12.1	16.2
P/FCF TTM (Sector)	13.5	13.3	12.1	8.5	14.0

	12/24/25	2024	2023
Share Price CYE	$20.28	$22.16	$29.04
Market Cap CYE ($ Mil)	150.3	168.4	227.3
Total Debt ($ Mil)	37.9	42.2	34.0
Total Cash ($ Mil)	1.3	4.7	6.3
Enterprise Value ($ Mil)	186.9	210.6	261.3
Valuation Ratios
P/S TTM	0.5	0.6	0.9
P/EBIT TTM	6.5	7.7	10.2
P/E TTM	11.5	12.9	14.3
P/FCF TTM	42.9	47.7	25.3
Sector Ratios
P/S TTM (Sector)	1.7	1.5	1.4
P/EBIT TTM (Sector)	12.9	11.9	11.2
P/E TTM (Sector)	17.1	16.5	15.4
P/FCF TTM (Sector)	13.5	13.3	12.1

	RCMT	S&P 500
REVENUE GROWTH	FAIR
Rev LTM ($ Bil)	0.3
Rev Chg Q	16.4%	7.3%
Rev Chg LTM	13.7%	6.1%
Rev Chg 3Y Avg	3.8%	5.5%
PROFITABILITY	VERY POOR
Op Inc LTM ($ Bil)	0.0
CFO LTM ($ Bil)	0.0
Net Inc LTM ($ Bil)	0.0
Op Mgn LTM	7.2%	18.8%
CFO/Rev LTM	1.9%	20.4%
Net Inc Mgn	4.2%	13.1%
VALUATION	MODERATE
P/S	0.5	3.2
P/CFO	25.5	15.7
P/FCF	42.9	20.6
P/E	11.5	23.5
STABILITY	FAIR
Debt/Equity	0.25	0.21
Cash/Assets	0.01	0.07

AI Analysis | Feedback

Metric	Value	Date	Source
Engineering Backlog	Record	10312025	Link

Upcoming
3/11/2026	Earnings Release	Rev: - EPS: -

RCMT Stock

Return (1M):

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Based on the available information for RCM Technologies (RCMT) from August 31, 2025, to December 24, 2025, the following key points may explain the stock's movement by -24.9%: 1. Q3 2025 GAAP Net Income Decline and Missed EPS Forecast

RCM Technologies reported a GAAP net income of $2.3 million, or $0.30 per diluted share, for the third quarter ended September 27, 2025, which was a decrease compared to $2.7 million, or $0.35 per diluted share, for the comparable prior quarter. This also represented a miss on the Q3 2025 EPS forecast by 34.78% ($0.30 vs $0.46 expected), despite revenue exceeding expectations. 2. Slight Decline in Adjusted EBITDA

The company experienced a slight decline in adjusted EBITDA (non-GAAP) for the third quarter of 2025, reaching $5.5 million compared to $5.6 million for the comparable prior quarter, representing a 1.4% decrease. Show more

Stock Movement Drivers

Fundamental Drivers

The -24.0% change in RCMT stock from 9/23/2025 to 12/23/2025 was primarily driven by a -21.1% change in the company's P/E Multiple.

	9232025	12232025	Change
Stock Price ($)	26.82	20.38	-24.00%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	299.92	309.84	3.31%
Net Income Margin (%)	4.53%	4.23%	-6.67%
P/E Multiple	14.62	11.53	-21.15%
Shares Outstanding (Mil)	7.41	7.41	-0.03%
Cumulative Contribution			-24.00%

LTM = Last Twelve Months as of date shown

Market Drivers

9/23/2025 to 12/23/2025

	Return	Correlation
RCMT	-24.0%
Market (SPY)	3.7%	28.8%
Sector (XLI)	2.6%	35.8%

Fundamental Drivers

The -11.8% change in RCMT stock from 6/24/2025 to 12/23/2025 was primarily driven by a -11.2% change in the company's P/E Multiple.

	6242025	12232025	Change
Stock Price ($)	23.11	20.38	-11.81%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	290.91	309.84	6.51%
Net Income Margin (%)	4.66%	4.23%	-9.32%
P/E Multiple	12.98	11.53	-11.18%
Shares Outstanding (Mil)	7.62	7.41	2.72%
Cumulative Contribution			-11.88%

LTM = Last Twelve Months as of date shown

Market Drivers

6/24/2025 to 12/23/2025

	Return	Correlation
RCMT	-11.8%
Market (SPY)	13.7%	30.1%
Sector (XLI)	8.7%	36.0%

Fundamental Drivers

The -6.9% change in RCMT stock from 12/23/2024 to 12/23/2025 was primarily driven by a -26.7% change in the company's Net Income Margin (%).

	12232024	12232025	Change
Stock Price ($)	21.88	20.38	-6.86%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	272.50	309.84	13.70%
Net Income Margin (%)	5.77%	4.23%	-26.70%
P/E Multiple	10.63	11.53	8.47%
Shares Outstanding (Mil)	7.63	7.41	2.95%
Cumulative Contribution			-6.94%

LTM = Last Twelve Months as of date shown

Market Drivers

12/23/2024 to 12/23/2025

	Return	Correlation
RCMT	-6.9%
Market (SPY)	16.7%	32.2%
Sector (XLI)	19.1%	33.5%

Fundamental Drivers

The 74.9% change in RCMT stock from 12/24/2022 to 12/23/2025 was primarily driven by a 114.7% change in the company's P/E Multiple.

	12242022	12232025	Change
Stock Price ($)	11.65	20.38	74.94%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	279.38	309.84	10.90%
Net Income Margin (%)	7.88%	4.23%	-46.38%
P/E Multiple	5.37	11.53	114.66%
Shares Outstanding (Mil)	10.15	7.41	27.04%
Cumulative Contribution			62.15%

LTM = Last Twelve Months as of date shown

Market Drivers

12/24/2023 to 12/23/2025

	Return	Correlation
RCMT	-30.2%
Market (SPY)	48.4%	27.8%
Sector (XLI)	42.3%	31.3%

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
RCMT Return	-31%	244%	73%	135%	-24%	-7%	584%
Peers Return	17%	44%	-17%	8%	-10%	-18%	13%
S&P 500 Return	16%	27%	-19%	24%	23%	17%	114%
Monthly Win Rates [3]
RCMT Win Rate	42%	75%	42%	75%	50%	50%
Peers Win Rate	60%	73%	43%	52%	48%	48%
S&P 500 Win Rate	58%	75%	42%	67%	75%	73%
Max Drawdowns [4]
RCMT Max Drawdown	-63%	-10%	-18%	-16%	-38%	-33%
Peers Max Drawdown	-43%	-7%	-28%	-17%	-21%	-30%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: AMN, CTSH, KBR, J, ASGN.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/23/2025 (YTD)

How Low Can It Go

Unique Key	Event	RCMT	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-63.1%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	171.3%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	269 days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-62.9%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	169.6%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	322 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-58.5%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	141.0%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	647 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-91.2%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	1035.2%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	4,754 days	1,480 days

Compare to HON, TTI, HHS, MMM, CSL

In The Past

RCM Technologies's stock fell -63.1% during the 2022 Inflation Shock from a high on 6/3/2022. A -63.1% loss requires a 171.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About RCM Technologies (RCMT)

Business Description Analogies Products Customers Suppliers Management Key Risks Emerging Threats Market Size Revenue Drivers Capital Allocation

RCM Technologies, Inc. provides business and technology solutions in the United States, Canada, Puerto Rico, and Serbia. It operates through three segments: Engineering, Specialty Health Care, and Life Sciences and Information Technology. The Engineering segment offers a range of engineering services, including project management engineering and design, engineering analysis, engineer-procure-construct, configuration management, hardware/software validation and verification, quality assurance, technical writing and publications, manufacturing process planning and improvement, and 3D/BIM integrated design. The Specialty Health Care segment provides long-term and short-term staffing, executive search, and placement services in the fields of allied and therapy staffing, correctional healthcare staffing, health information management, nursing services, physician and advanced practice, school services, and telepractice. The Life Sciences and Information Technology segment provides enterprise business solutions, application services, infrastructure solutions, competitive advantage, life sciences solutions, and other vertical market specific solutions. The company serves aerospace and defense, energy, financial services, health care, life sciences, manufacturing and distribution, and technology industries, as well as educational institutions and the public sector. RCM Technologies, Inc. was founded in 1971 and is based in Pennsauken, New Jersey.

AI Analysis | Feedback

A specialized IT and engineering professional services firm, similar to a smaller TEKsystems or Cognizant.

Like Robert Half or Randstad, but providing specialized IT, engineering, and life sciences project solutions and expert staffing.

AI Analysis | Feedback

Engineering Services: Provides design, development, and support services across various industries, including aerospace, defense, automotive, and energy.
Life Sciences & Information Technology Services: Offers IT consulting, digital transformation, data analytics, and clinical research services, primarily for the life sciences and healthcare sectors.
Specialty Health Care Services: Delivers staffing solutions for healthcare professionals, such as nurses and therapists, to educational, governmental, and medical institutions.

AI Analysis | Feedback

RCM Technologies (RCMT) primarily sells its services to other companies and government entities, operating on a Business-to-Business (B2B) model.

Based on their latest financial filings (10-K), no single customer accounted for more than 10% of RCM Technologies' consolidated revenues for the years ended December 31, 2023, 2022, or 2021. Therefore, no specific "major customer" companies are individually named or disclosed in their public reports as meeting this threshold.

Instead, RCM Technologies serves a diverse client base across a wide range of industries and sectors through its three primary business segments:

Information Technology (IT) Segment: Serves clients in sectors such as financial services, healthcare, energy, manufacturing, retail, pharmaceuticals, life sciences, and various government agencies.
Engineering Segment: Provides services to clients in the power generation, process and industrial, and government sectors.
Healthcare Segment: Offers staffing solutions primarily to hospitals, schools, and other healthcare providers.

Given the absence of individually named major customers, the company's customer base is best characterized by the variety of industries and organizational types it supports, rather than specific entities.

AI Analysis | Feedback

null

AI Analysis | Feedback

Bradley S. Vizi Executive Chairman & President

Mr. Vizi has served as the Executive Chairman and President of RCM Technologies since June 2018, having previously been Chairman of the Board since September 2015 and a board member since December 2013. He is the founder of Legion Partners Asset Management, LLC, where he served as Managing Director and Portfolio Manager from 2012 to 2017. Prior to founding Legion Partners, Mr. Vizi was an investment professional at Shamrock Capital Advisors, Inc. from 2007 to 2010, and before that, with the private equity group at Kayne Anderson Capital Advisors L.P. from 2006 to 2007.

Kevin D. Miller Chief Financial Officer

Mr. Miller has been the Chief Financial Officer of RCM Technologies since October 2008. He previously served as Senior Vice President of the company from 1997 to 2008. Before joining RCM, he was an Associate in the corporate finance department of Legg Mason Wood Walker from 1996 to 1997 and served as a Business Consultant for the Wharton Small Business Development Center. Mr. Miller began his career at EY and has expertise in strategic planning and private equity.

Michael Saks President - Health Care Services

Mr. Saks has served as President of Health Care Services for RCM Technologies since 2018. Prior to this role, he was the Senior Vice President of Health Care Services.

Tina Ciocca Executive Vice President - Aerospace Division

Ms. Ciocca has been the Executive Vice President of the Aerospace Division since 2021.

William Gargano Group Senior Vice President, Life Sciences & IT Services

Mr. Gargano holds the title of Group Senior Vice President, Life Sciences & IT Services.

AI Analysis | Feedback

The key risks to RCM Technologies (RCMT) include its reliance on a concentrated customer base and specific business segments, vulnerability to macroeconomic changes, and the potential for margin compression due to competitive pressures.

Customer and Segment Concentration Risk: RCM Technologies derives a significant portion of its revenue from a limited number of customers and is heavily reliant on its Specialty Health Care and Engineering segments for growth. In fiscal year 2023, two customers accounted for over 10% each of the consolidated revenue, with the top five, ten, and twenty largest customers contributing approximately 39.1%, 50.4%, and 62.7% of the total revenue, respectively. This "segmental overreliance" exposes the company to vulnerabilities if client priorities shift or if there are downturns in these specific sectors. A substantial change in these key customer accounts could significantly impact the company's financial performance.
Macroeconomic Headwinds: The IT staffing and solutions sector, in which RCM Technologies operates, is sensitive to broader macroeconomic shifts. The company faces risks from factors such as rising interest rates, potential economic slowdowns or recessions, and regulatory changes in key industries like healthcare or engineering. Such macroeconomic pressures can disrupt demand for RCM's services and make it challenging to maintain profitability.
Margin Compression and Competitive Pressures: RCM Technologies has experienced some gross margin compression, indicating potential pricing pressures in the highly competitive IT staffing and solutions market. This compression could worsen if the company faces increased input costs or intensified pricing wars. The ability of RCM to sustain its profitability depends on its capacity to innovate and effectively differentiate its service offerings in a competitive landscape.

AI Analysis | Feedback

null

AI Analysis | Feedback

RCM Technologies (RCMT) operates in three primary business segments: Engineering Services, Specialty Healthcare Services, and Life Sciences, Data & Solutions/Information Technology (IT) Services. The addressable markets for these services are as follows:

Engineering Services

Overall Engineering Services (Global): The global engineering services market was estimated to be between approximately USD 1.80 trillion and USD 3.50 trillion in 2024. It is projected to grow to a range of USD 3.76 trillion to USD 5.51 trillion by 2034.
Aerospace Engineering Services (Global): The global aerospace engineering services outsourcing market reached USD 114.8 billion in 2024 and is expected to grow to USD 622.5 billion by 2033.
Energy Services (Global): The global Energy as a Service (EaaS) market, relevant to RCM Technologies' energy solutions, was valued at approximately USD 74.43 billion to USD 107.59 billion in 2024/2025. This market is projected to reach between USD 145.18 billion and USD 184.67 billion by 2030-2033.
Industrial Services (Global): The industrial services market, which includes engineering and consulting, is projected to reach USD 54.69 billion by 2030, growing from USD 34.41 billion in 2025.

Specialty Healthcare Services

Healthcare Staffing (Global): The global healthcare staffing market was valued at approximately USD 42.27 billion to USD 44.1 billion in 2024. It is projected to grow to a range of USD 71.9 billion to USD 82.92 billion by 2033-2034.
Healthcare Staffing (U.S.): The U.S. healthcare staffing market was estimated at USD 19.5 billion in 2024 and is projected to reach USD 34.09 billion by 2034.

Life Sciences, Data & Solutions / Information Technology (IT) Services

IT Consulting Services (Global): The global IT consulting services market was valued between approximately USD 68.8 billion (in 2022) and USD 117.1 billion (in 2025). Projections indicate growth to between USD 88.01 billion (by 2032) and USD 278.779 billion (by 2033).
IT Staffing (Global): The global IT staffing market is valued at approximately USD 117.4 billion currently and is projected to reach USD 147.58 billion by 2030.
Life Sciences Consulting Services (Global): The global life sciences consulting services market was valued between approximately USD 13.91 billion and USD 34.82 billion in 2024/2025. It is anticipated to reach between USD 21.94 billion and USD 84.83 billion by 2030-2034.

AI Analysis | Feedback

RCM Technologies (RCMT) is expected to drive future revenue growth over the next 2-3 years through several key initiatives across its diverse segments:

Growth in Healthcare Segment, particularly K-12 Behavioral Health and School Contracts: The company has demonstrated strong growth in its healthcare sector, specifically in school revenue and by securing a record number of new school contracts. This expansion includes a significant focus on K-12 behavioral health services. For instance, school revenue for Q1 2025 grew by 16.7% compared to Q1 2024. Management anticipates continued robust growth in K-12 healthcare contracts.
Expansion in Engineering Services, especially Energy Services and Aerospace & Defense: The Engineering segment is a significant growth driver, with strong performance in areas like grid modernization, data center expansions, and new client acquisitions within the aerospace and defense sectors. RCM Technologies reported its best engineering gross profit quarter in Q1 2025, and its Energy Services backlog for 2026 is projected to exceed $70 million, indicating robust future demand. The company is also seeing significant ramp-up in the aerospace and defense environment, particularly with clients doing business with the U.S. government.
Strategic Initiatives in IT, Life Sciences, and Data Solutions, including AI and Machine Learning: RCM Technologies is actively deploying technology within its IT, Life Sciences, and Data Solutions segment, with a particular emphasis on AI and machine learning. This includes expanding service offerings and focusing on operational efficiencies through technology.
Expansion of Client Base and Market Share: A consistent theme across RCM Technologies' segments is the successful acquisition of new clients and the expansion of services with existing ones. The company has maintained a high renewal rate (over 90%) and continues to land new clients while expanding existing relationships. This strategy contributes to overall market share gains and revenue growth.
Geographic Expansion: RCM Technologies is expanding its global footprint, notably by opening an office in Germany to become a preferred partner for the energy transition in Europe. The company is also focusing on building offshore capabilities to support future growth.

AI Analysis | Feedback

Share Repurchases

RCM Technologies authorized a share repurchase program in March 2024, allowing for repurchases of up to $50.0 million, inclusive of prior authorizations.
The company repurchased 301,640 shares at an average price of $16.89 per share during the first 39 weeks ended September 27, 2025, with $37.1 million remaining under the current authorization.
In the first nine months of 2023, RCM Technologies spent a total of $24.4 million on share buybacks. In 2024, approximately 400,000 shares were repurchased at an average price of $19.08 per share.

Share Issuance

RCM Technologies has issued shares primarily through employee stock purchase plans and the vesting of restricted share awards.
In the twenty-six weeks ended June 29, 2024, the company purchased 280,378 shares, while during the twenty-six weeks ended July 1, 2023, the Company awarded 4,762 immediately vested share awards at an average price of $10.50.

Outbound Investments

In October 2022, RCM Technologies acquired TalentHerder, a talent acquisition services company, to enhance its recruitment process outsourcing (RPO) capabilities and candidate sourcing reach.

Capital Expenditures

RCM Technologies' capital expenditures have been minimal, generally aligning with depreciation and amortization, allowing management to allocate excess cash flows towards share repurchases.

Better Bets than RCM Technologies (RCMT)

INDUSTRY: Industrial Conglomerates

Higher Rev Chg 3Y Avg | Lower P/S (Values for RCMT: 3.8% | 0.5x)

BOOM (5.4% | 0.2x)

DMC Global

TUSK (10.1% | 0.4x)

Mammoth Energy Services

AIRT (11.6% | 0.2x)

Air T

Higher Rev Chg LTM (Value for RCMT: 13.7%)

TUSK (80.7%)

Mammoth Energy Services

FIP (32.4%)

FTAI Infrastructure

FBYD (28.5%)

Falcons Beyond Global

TRC (15.7%)

Tejon Ranch

CSW (14.9%)

CSW Industrials

Higher Rev Chg 3Y Avg (Value for RCMT: 3.8%)

FIP (23.3%)

FTAI Infrastructure

BOC (15.5%)

Boston Omaha

CSW (11.3%)

CSW Industrials

TTI (6.4%)

Tetra Technologies

HON (5.2%)

Honeywell International

Higher Op Mgn LTM (Value for RCMT: 7.2%)

CSL (20.7%)

Carlisle Companies

MMM (20.5%)

CSW (19.3%)

CSW Industrials

HON (18.9%)

Honeywell International

TTI (9.8%)

Tetra Technologies

Higher CFO/Rev LTM (Value for RCMT: 1.9%)

CSL (21.7%)

Carlisle Companies

HON (18.4%)

Honeywell International

CSW (16.7%)

CSW Industrials

MMM (10.2%)

SEB (6.9%)

Seaboard

Higher FCF/Rev LTM (Value for RCMT: 1.1%)

CSL (19.1%)

Carlisle Companies

CSW (15.2%)

CSW Industrials

HON (15.2%)

Honeywell International

MMM (6.4%)

SEB (1.2%)

Seaboard

Higher Total Yield (Value for RCMT: 8.7%)

SEB (9.8%)

Seaboard

TTI (9.8%)

Tetra Technologies

SECTOR: Industrials

Higher Rev Chg 3Y Avg | Lower P/S (Values for RCMT: 3.8% | 0.5x)

AAL (6.5% | 0.2x)

American Airlines

FLR (4.7% | 0.4x)

Fluor

GXO (13.7% | 0.5x)

GXO Logistics

ALK (16.5% | 0.4x)

Alaska Air

ABM (3.9% | 0.3x)

ABM Industries

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for RCMT: 3.8% | 6.8x)

AAL (6.5% | 4.6x)

American Airlines

OC (7.1% | 5.2x)

Owens-Corning

SKYW (9.4% | 6.6x)

SkyWest

WSC (6.8% | 6.5x)

WillScot

CNXC (17.9% | 4.1x)

Concentrix

Higher Rev Chg LTM (Value for RCMT: 13.7%)

VRT (28.8%)

Vertiv

PWR (18.7%)

Quanta Services

UBER (18.2%)

Uber Technologies

GE (17.7%)

GE Aerospace

WM (15.9%)

Waste Management

Higher Rev Chg 3Y Avg (Value for RCMT: 3.8%)

UBER (19.6%)

Uber Technologies

GE (15.7%)

GE Aerospace

BA (10.1%)

Boeing

RTX (9.4%)

RTX

CAT (4.9%)

Caterpillar

Higher Op Mgn LTM (Value for RCMT: 7.2%)

UNP (40.6%)

Union Pacific

GE (20.5%)

GE Aerospace

CAT (17.7%)

Caterpillar

RTX (10.3%)

RTX

UBER (9.2%)

Uber Technologies

Higher CFO/Rev LTM (Value for RCMT: 1.9%)

UBER (18.1%)

Uber Technologies

CAT (17.8%)

Caterpillar

GE (17.2%)

GE Aerospace

RTX (9.3%)

RTX

GEV (9.1%)

GE Vernova

Higher FCF/Rev LTM (Value for RCMT: 1.1%)

UBER (17.5%)

Uber Technologies

GE (14.7%)

GE Aerospace

CAT (11.7%)

Caterpillar

GEV (6.6%)

GE Vernova

RTX (5.5%)

RTX

Higher Total Yield (Value for RCMT: 8.7%)

TDG (15.3%)

TransDigm

UPS (12.8%)

United Parcel Service

CNI (11.1%)

Canadian National Railway

DAL (10.6%)

Delta Air Lines

UBER (9.9%)

Uber Technologies

All Other Sectors

Higher Rev Chg 3Y Avg | Lower P/S (Values for RCMT: 3.8% | 0.5x)

MCK (12.6% | 0.3x)

McKesson

CVS (7.7% | 0.3x)

CVS Health

GM (8.6% | 0.4x)

General Motors

ELV (8.4% | 0.4x)

Elevance Health

CI (13.6% | 0.3x)

Cigna

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for RCMT: 3.8% | 6.8x)

FISV (6.8% | 6.0x)

Fiserv

FI (7.5% | 5.5x)

Fiserv

IBKR (48.1% | 3.5x)

Interactive Brokers

RCI (11.8% | 4.1x)

Rogers Communications

JEF (14.6% | 2.9x)

Jefferies Financial

Higher Rev Chg LTM (Value for RCMT: 13.7%)

NVDA (65.2%)

NVIDIA

LLY (36.8%)

Eli Lilly

AVGO (23.9%)

Broadcom

META (21.3%)

Meta Platforms

MSFT (15.6%)

Microsoft

Higher Rev Chg 3Y Avg (Value for RCMT: 3.8%)

NVDA (91.6%)

NVIDIA

META (17.3%)

Meta Platforms

MSFT (13.2%)

Microsoft

AMZN (11.3%)

Amazon.com

GOOGL (11.0%)

Alphabet

Higher Op Mgn LTM (Value for RCMT: 7.2%)

NVDA (58.8%)

NVIDIA

MSFT (46.3%)

Microsoft

GOOGL (32.2%)

Alphabet

AAPL (31.9%)

Apple

AMZN (11.4%)

Amazon.com

Higher CFO/Rev LTM (Value for RCMT: 1.9%)

MSFT (50.0%)

Microsoft

NVDA (44.4%)

NVIDIA

GOOGL (39.3%)

Alphabet

AAPL (26.6%)

Apple

AMZN (18.1%)

Amazon.com

Higher FCF/Rev LTM (Value for RCMT: 1.1%)

NVDA (41.3%)

NVIDIA

MSFT (26.6%)

Microsoft

AAPL (23.5%)

Apple

GOOGL (19.1%)

Alphabet

AMZN (2.0%)

Amazon.com

Higher Total Yield (Value for RCMT: 8.7%)

VZ (18.5%)

Verizon Communications

T (12.7%)

AT&T

MRK (10.4%)

Merck

XOM (9.2%)

Exxon Mobil

WFC (8.8%)

Wells Fargo

		Best Bets In Industrials Sector
	RCMT	GATX	VRSK	PAYX	ADT	AGX	PCTY	TDG	FTV	VRRM	CSW
What You Pay
P/E	11.5	19.9	33.1	25.7	10.3	38.4	37.5	36.9	30.6	69.5	35.9
P/EBIT	6.5	9.6	22.6	17.7	5.2	38.5	26.9	18.2	14.9	20.6	27.7
What You Get
Rev Chg Q	16.4%	8.4%	5.9%	18.3%	4.4%	-2.3%	12.5%	11.5%	2.3%	16.1%	21.5%
Rev Chg LTM	13.7%	10.7%	7.3%	12.4%	6.3%	13.5%	13.3%	11.2%	27.9%	8.5%	14.9%
Rev Chg 3Y Avg	3.8%	10.3%	13.4%	7.9%	3.4%	26.9%	21.4%	17.7%	9.4%	9.1%	11.3%
FCF/Rev 3Y Avg	3.4%	39.2%	33.2%	32.6%	24.7%	24.5%	21.5%	21.0%	20.1%	19.0%	18.9%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 16%, alpha of 4.2%, and sharpe of 0.76

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	RCM Technologies Earnings Notes
2	Would You Still Hold RCM Technologies Stock If It Fell 30%?	Return

	Title
0	ARTICLES

Trade Ideas

Select ideas related to RCMT. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
CNM_11212025_Dip_Buyer_FCFYield	11212025	CNM	Core & Main	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	17.7%	17.7%	-1.6%
VRRM_11212025_Dip_Buyer_FCFYield	11212025	VRRM	Verra Mobility	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	4.4%	4.4%	-1.2%
LII_11212025_Dip_Buyer_ValueBuy	11212025	LII	Lennox International	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	6.3%	6.3%	0.0%
ADP_11212025_Monopoly_xInd_xCD_Getting_Cheaper	11212025	ADP	Automatic Data Processing	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	2.2%	2.2%	-1.2%
CW_11212025_Quality_Momentum_RoomToRun_10%	11212025	CW	Curtiss-Wright	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	6.3%	6.3%	-0.4%

Recent Active Movers

Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
RZLT	Rezolute	0.3	18.0%	-50.6%
WW	WW International	2.4	14.2%
NRGV	Energy Vault	0.8	10.4%	122.8%
METC	Ramaco Resources	1.0	8.5%	67.0%
UAMY	United States Antimony	0.7	7.9%	240.7%
LION	Lionsgate Studios	2.6	7.4%	-71.0%
GHM	Graham	0.8	7.3%	56.3%
VG	Venture Global	17.0	6.4%
CRK	Comstock Resources	6.7	5.7%	26.6%
SSII	SS Innovations International	1.1	5.5%	-25.0%

Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
TPL	Texas Pacific Land	6.8	-67.3%	-18.9%
GOSS	Gossamer Bio	0.7	-12.9%	263.1%
CSIQ	Canadian Solar	1.6	-11.8%	115.2%
TDUP	ThredUp	0.8	-11.7%	363.3%
LAB	Standard BioTools	0.6	-11.0%	-14.6%
INBX	Inhibrx Biosciences	1.2	-10.8%	407.0%
QBTS	D-Wave Quantum	10.0	-9.5%	246.7%
FDMT	4D Molecular Therapeutics	0.4	-9.3%	41.8%
FBYD	Falcons Beyond Global	0.6	-8.5%	109.8%
PVLA	Palvella Therapeutics	1.1	-8.1%	735.6%

Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
LUNR	Intuitive Machines	1.9	53.2%	-9.1%
HUT	Hut 8	5.5	42.4%	156.1%
AAOI	Applied Optoelectronics	2.6	40.3%	10.3%
FBYD	Falcons Beyond Global	0.6	39.8%	109.8%
RKLB	Rocket Lab	39.8	39.1%	203.0%
DJT	Trump Media & Technology	3.9	31.9%	-58.5%
SGML	Sigma Lithium	1.5	31.9%	20.2%
ADEA	Adeia	1.9	31.0%	23.9%
TE	T1 Energy	1.1	30.7%
FOLD	Amicus Therapeutics	4.4	30.5%	50.8%

Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
NOW	ServiceNow	32.0	-80.2%	-27.2%
TPL	Texas Pacific Land	6.8	-63.8%	-18.9%
FDMT	4D Molecular Therapeutics	0.4	-31.4%	41.8%
LW	Lamb Weston	5.9	-30.1%	-35.8%
TLRY	Tilray Brands	11.2	-24.5%	-20.8%
OLMA	Olema Pharmaceuticals	2.4	-19.3%	374.6%
INSP	Inspire Medical Systems	2.8	-17.8%	-48.8%
GETY	Getty Images	0.5	-17.6%	-41.7%
TDUP	ThredUp	0.8	-16.4%	363.3%
FRMI	Fermi	5.8	-15.3%

Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
TE	T1 Energy	1.1	161.4%
WVE	WAVE Life Sciences	2.9	147.9%	41.3%
AAOI	Applied Optoelectronics	2.6	97.5%	10.3%
LUNR	Intuitive Machines	1.9	91.5%	-9.1%
RKLB	Rocket Lab	39.8	91.5%	203.0%
VERA	Vera Therapeutics	3.4	89.4%	27.5%
PL	Planet Labs PBC	6.3	85.8%	413.1%
ANF	Abercrombie & Fitch	5.9	77.2%	-17.2%
ARWR	Arrowhead Pharmaceuticals	9.7	72.6%	271.4%
NRGV	Energy Vault	0.8	68.8%	122.8%

Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
RZLT	Rezolute	0.3	-75.4%	-50.6%
JANX	Janux Therapeutics	0.9	-51.0%	-73.6%
LENZ	LENZ Therapeutics	0.5	-42.9%	-41.5%
FRMI	Fermi	5.8	-42.5%
GOGO	Gogo	0.6	-35.0%	-43.3%
HPK	HighPeak Energy	0.5	-29.7%	-70.1%
UP	Wheels Up Experience	0.4	-29.2%	-61.8%
ORIC	ORIC Pharmaceuticals	0.6	-28.8%	2.5%
LW	Lamb Weston	5.9	-27.5%	-35.8%
ACLX	Arcellx	3.7	-27.4%	-14.6%

Peer Comparisons for RCM Technologies

Peers to compare with:

Financials

	RCMT	AMN	CTSH	KBR	J	ASGN	Median
Name	RCM Tech.	AMN Heal.	Cognizan.	KBR	Jacobs S.	ASGN
Mkt Price	20.38	15.99	85.18	39.98	135.86	48.92	44.45
Mkt Cap	0.2	0.6	41.4	5.1	16.2	2.1	3.6
Rev LTM	310	2,717	20,857	8,078	12,030	3,985	6,032
Op Inc LTM	22	45	3,274	543	864	248	396
FCF LTM	4	223	2,651	494	607	283	389
FCF 3Y Avg	9	254	2,089	378	793	347	363
CFO LTM	6	267	2,945	559	687	326	442
CFO 3Y Avg	11	334	2,394	453	905	386	419

Growth & Margins

	RCMT	AMN	CTSH	KBR	J	ASGN	Median
Name	RCM Tech.	AMN Heal.	Cognizan.	KBR	Jacobs S.	ASGN
Rev Chg LTM	13.7%	-11.4%	7.4%	10.2%	4.6%	-4.9%	6.0%
Rev Chg 3Y Avg	3.8%	-20.6%	2.6%	3.0%	7.2%	-3.8%	2.8%
Rev Chg Q	16.4%	-7.7%	7.4%	-0.3%	6.6%	-1.9%	3.1%
QoQ Delta Rev Chg LTM	3.3%	-1.9%	1.8%	-0.1%	1.6%	-0.5%	0.8%
Op Mgn LTM	7.2%	1.7%	15.7%	6.7%	7.2%	6.2%	7.0%
Op Mgn 3Y Avg	8.1%	5.5%	15.2%	7.0%	6.5%	7.3%	7.1%
QoQ Delta Op Mgn LTM	-0.4%	-0.5%	0.2%	-0.3%	0.0%	-0.2%	-0.3%
CFO/Rev LTM	1.9%	9.8%	14.1%	6.9%	5.7%	8.2%	7.5%
CFO/Rev 3Y Avg	4.2%	9.8%	12.0%	6.0%	8.0%	9.1%	8.5%
FCF/Rev LTM	1.1%	8.2%	12.7%	6.1%	5.0%	7.1%	6.6%
FCF/Rev 3Y Avg	3.4%	7.4%	10.4%	5.0%	7.0%	8.2%	7.2%

Valuation

	RCMT	AMN	CTSH	KBR	J	ASGN	Median
Name	RCM Tech.	AMN Heal.	Cognizan.	KBR	Jacobs S.	ASGN
Mkt Cap	0.2	0.6	41.4	5.1	16.2	2.1	3.6
P/S	0.5	0.2	2.0	0.6	1.3	0.5	0.6
P/EBIT	6.5	-2.3	12.2	7.1	23.5	8.6	7.8
P/E	11.5	-2.2	19.5	13.5	56.1	16.3	14.9
P/CFO	25.7	2.3	14.1	9.2	23.6	6.5	11.6
Total Yield	8.7%	-44.6%	5.5%	9.0%	2.2%	6.1%	5.8%
Dividend Yield	0.0%	0.0%	0.4%	1.6%	0.5%	0.0%	0.2%
FCF Yield 3Y Avg	5.6%	16.6%	6.1%	5.3%	4.7%	10.8%	5.8%
D/E	0.3	1.4	0.0	0.6	0.2	0.5	0.4
Net D/E	0.2	1.3	-0.0	0.5	0.1	0.5	0.4

Returns

	RCMT	AMN	CTSH	KBR	J	ASGN	Median
Name	RCM Tech.	AMN Heal.	Cognizan.	KBR	Jacobs S.	ASGN
1M Rtn	4.4%	-3.2%	12.1%	-0.5%	5.8%	13.8%	5.1%
3M Rtn	-24.0%	-13.1%	26.4%	-16.1%	-7.9%	0.7%	-10.5%
6M Rtn	-11.8%	-26.3%	10.8%	-15.8%	5.4%	-1.8%	-6.8%
12M Rtn	-6.9%	-31.1%	9.6%	-29.4%	2.4%	-41.5%	-18.1%
3Y Rtn	74.9%	-84.5%	59.8%	-21.0%	40.3%	-40.2%	9.6%
1M Excs Rtn	-0.3%	-7.9%	7.5%	-5.1%	1.1%	9.1%	0.4%
3M Excs Rtn	-28.0%	-16.9%	21.1%	-23.0%	-11.7%	-4.6%	-14.3%
6M Excs Rtn	-24.5%	-37.5%	-1.8%	-29.6%	-6.8%	-15.4%	-19.9%
12M Excs Rtn	-23.8%	-48.1%	-8.9%	-47.1%	-14.4%	-60.0%	-35.4%
3Y Excs Rtn	-38.7%	-164.1%	-18.3%	-98.6%	-37.0%	-119.2%	-68.7%

FDIC Bank Data

Bank Capital

null

Bank Deposits

null

Bank Assets

null

Bank Loans

null

FDA Approved Drugs Data

Expand for Morenull

Financials

Annual
Quarterly

$ Mil \| FY: 12/28	LTM	2024	2023	2022	2021	2020	2019
Period End	9/27/2025	12/28/2024	12/31/2023	12/31/2022	1/1/2022	1/2/2021	12/28/2019
Filing Date	11/6/2025	3/13/2025	3/14/2024	3/16/2023	4/4/2022	4/2/2021	3/5/2020
Key Financials
Total Revenue	310	278	263	285	204	150	191
EBITDA	26	25	25	30	15	-8	8
Operating Income	22	21	23	28	10	-0	7
Net Income	13	13	17	21	11	-9	4
EPS	1.74	1.72	2.03	2.08	1.00	-0.73	0.31
Growth Rates
Total Revenue Growth	13.7%	5.8%	-7.5%	39.6%	35.5%	-21.3%	-4.6%
EBITDA Growth	1.1%	-1.2%	-17.0%	94.3%	283.0%	-203.7%	16.7%
Operating Income Growth	-7.0%	-8.0%	-18.2%	184.8%	3206.5%	-104.9%	-6.0%
Net Income Growth	-16.7%	-20.8%	-19.4%	90.1%	223.9%	-318.6%	49.5%
Margins
EBITDA Margin	8.2%	8.8%	9.4%	10.5%	7.5%	-5.6%	4.2%
Operating Income Margin	7.2%	7.7%	8.9%	10.0%	4.9%	-0.2%	3.4%
Net Income Margin	4.2%	4.8%	6.4%	7.3%	5.4%	-5.9%	2.1%
Cash & Debt
Total Cash	1	5	6	0	0	1	2
Total Debt	38	42	34	14	18	17	41
Net Debt / (Cash)	37	37	28	13	18	16	39
Cash Flows
Net Cash from Operations	6	6	12	28	1	25	-5
Free Cash from Operations	4	4	10	27	0	25	-5
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	-0
Share Repurchases	6	9	26	18	9	2	-0

$ Mil \| FY: 12/28	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4
Period End	9/27/2025	6/28/2025	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/31/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022
Filing Date	11/6/2025	8/7/2025	5/8/2025	3/13/2025	11/7/2024	8/8/2024	5/9/2024	3/14/2024	11/9/2023	8/10/2023	5/10/2023	3/16/2023
Key Financials Quarterly
Total Revenue	70	78	84	77	60	69	72	71	58	67	67	70
Ebitda	4	7	7	7	5	6	6	8	5	6	6	7
Operating Income	4	7	7	5	4	6	6	8	4	6	5	7
Net Income	2	4	4	3	3	4	4	5	4	4	4	5
EPS	0.30	0.51	0.55	0.38	0.36	0.48	0.50	0.67	0.47	0.48	0.42	0.52
Key Financials TTM
Total Revenue TTM	310	300	291	278	272	270	268	263	262	263	270	285
Ebitda TTM	26	26	25	25	25	25	25	25	24	24	27	30
Operating Income TTM	22	23	22	21	24	24	24	23	22	22	25	28
Net Income TTM	13	14	14	13	16	17	17	17	16	16	18	21
Growth Rates Quarterly
Total Revenue Growth	16.4%	13.0%	17.4%	8.3%	4.0%	3.2%	7.2%	1.1%	-0.2%	-9.8%	-18.1%	8.2%
EBITDA Growth	-5.3%	8.4%	11.9%	-9.1%	0.7%	2.6%	4.1%	17.1%	-8.9%	-29.0%	-35.9%	-6.1%
Operating Income Growth	-10.2%	13.4%	12.8%	-35.0%	1.2%	1.2%	9.9%	17.6%	-4.6%	-29.8%	-41.2%	31.6%
Net Income Growth	-17.7%	0.6%	5.9%	-45.4%	-26.9%	-5.5%	3.0%	8.6%	6.8%	-33.8%	-41.2%	-19.0%
Margins Quarterly
EBITDA Margin	6.3%	8.6%	8.2%	9.6%	7.8%	9.0%	8.6%	11.4%	8.0%	9.0%	8.9%	9.9%
Operating Income Margin	5.6%	8.4%	7.8%	6.7%	7.3%	8.4%	8.1%	11.1%	7.5%	8.6%	7.9%	9.6%
Net Income Margin	3.2%	4.8%	5.0%	3.7%	4.5%	5.4%	5.5%	7.4%	6.5%	5.9%	5.7%	6.9%
Cash & Debt
Total Cash	1	5	5	5	3	3	2	6	1	1	2	0
Total Debt	38	41	30	42	38	30	26	34	10	19	24	14
Net Debt / (Cash)	37	35	25	37	35	26	23	28	10	18	22	13
Cash Flows Quarterly
FCF from Operations	-1	-8	17	-2	-4	6	6	-15	11	17	-1	8
Cash Flows TTM
FCF from Operations TTM	6	3	16	6	-7	8	20	12	35	24	25	28
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	1	4	1	2	4	1	1	3	13	8	11
Return on Invested Capital (ROIC) Quarterly
ROIC	29.3%	50.1%	74.1%	27.3%	36.7%	63.8%	72.8%	81.3%	161.5%	97.4%	50.3%	53.5%
Return on Invested Capital (ROIC) TTM
ROIC TTM	38.6%	41.6%	56.9%	37.3%	49.6%	68.8%	77.2%	63.7%	177.3%	93.4%	59.4%	55.5%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Specialty Health Care	136	159	98	60	89
Engineering	85	86	66	58	68
Life Sciences, Data & Solutions	42	39
Corporate	0	0
Information Technology			39	32	34
Total	263	285	204	150	191

Operating Income by Segment

$ Mil	2024	2023	2022	2021	2020
Specialty Health Care	14	20	5	-3	3
Life Sciences, Data & Solutions	7	5
Engineering	4	4	5	-6	4
Corporate	0	0		-2	-0
Information Technology			3	-0	0
Total	24	29	14	-11	7

Assets by Segment

$ Mil	2024	2023	2022	2021	2020
Engineering	46	33	28	34	52
Specialty Health Care	44	34	33	19	30
Life Sciences, Data & Solutions	19	16
Corporate	12	5	3	8	6
Information Technology			9	7	8
Total	120	88	73	68	96

Price Behavior

Price Behavior

Market Price	$20.38
Market Cap ($ Bil)	0.2
First Trading Date	08/18/1995
Distance from 52W High	-25.9%
	50 Days	200 Days
DMA Price	$21.05	$21.96
DMA Trend	indeterminate	down
Distance from DMA	-3.2%	-7.2%
	3M	1YR
Volatility	36.6%	42.5%
Downside Capture	93.43	96.51
Upside Capture	-53.23	74.67
Correlation (SPY)	29.0%	32.2%

RCMT Betas & Captures as of 11/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.98	0.79	0.78	0.98	0.71	0.73
Up Beta	2.66	2.65	2.50	2.61	0.76	0.68
Down Beta	2.62	1.22	1.40	0.94	0.52	0.70
Up Capture	-105%	-93%	-75%	12%	52%	47%
Bmk +ve Days	13	26	39	74	142	427
Stock +ve Days	5	13	23	49	109	362
Down Capture	115%	101%	81%	84%	94%	94%
Bmk -ve Days	7	16	24	52	107	323
Stock -ve Days	15	29	40	75	138	382

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Based On 1-Year Data

		Comparison of RCMT With Other Asset Classes (Last 1Y)
	RCMT	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-5.3%	20.4%	18.8%	72.9%	9.0%	3.7%	-11.4%
Annualized Volatility	42.3%	18.8%	19.5%	19.2%	15.3%	17.2%	35.0%
Sharpe Ratio	-0.02	0.85	0.76	2.72	0.36	0.05	-0.14
Correlation With Other Assets		33.5%	32.2%	-4.6%	10.3%	21.7%	12.7%

ETFs used for asset classes: Sector ETF = XLI, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

		Comparison of RCMT With Other Asset Classes (Last 5Y)
	RCMT	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	63.8%	13.8%	14.8%	18.9%	11.8%	4.7%	35.5%
Annualized Volatility	74.5%	17.2%	17.1%	15.5%	18.7%	18.9%	48.9%
Sharpe Ratio	0.96	0.64	0.70	0.98	0.51	0.16	0.62
Correlation With Other Assets		19.7%	21.8%	-3.1%	4.4%	16.5%	10.9%

Based On 10-Year Data

		Comparison of RCMT With Other Asset Classes (Last 10Y)
	RCMT	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	18.0%	13.5%	14.8%	15.1%	6.8%	5.4%	69.1%
Annualized Volatility	64.9%	19.9%	18.0%	14.8%	17.6%	20.8%	55.8%
Sharpe Ratio	0.52	0.60	0.71	0.85	0.31	0.23	0.90
Correlation With Other Assets		20.8%	20.5%	-1.0%	7.3%	17.9%	10.5%

Short Interest

Short Interest: As Of Date	11282025
Short Interest: Shares Quantity	226,548
Short Interest: % Change Since 11152025	6.3%
Average Daily Volume	50,061
Days-to-Cover Short Interest	4.53
Basic Shares Quantity	7,409,009
Short % of Basic Shares	3.1%

Returns Analyses

	Title
0	Would You Still Hold RCM Technologies Stock If It Fell 30%?

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
11/5/2025	-5.0%	-17.3%	-14.2%
8/7/2025	0.0%	8.7%	20.8%
3/12/2025	-13.5%	-16.2%	-8.9%
11/7/2024	4.2%	-1.8%	5.7%
8/7/2024	6.1%	2.9%	4.6%
3/13/2024	-24.9%	-19.0%	-32.3%
11/8/2023	14.1%	26.4%	41.0%
8/9/2023	-10.1%	1.7%	0.9%
...
SUMMARY STATS
# Positive	9	7	9
# Negative	9	11	9
Median Positive	4.2%	8.7%	20.0%
Median Negative	-6.7%	-11.1%	-11.6%
Max Positive	14.9%	41.3%	103.7%
Max Negative	-24.9%	-19.0%	-45.1%

	Forward Returns
11/5/2025	-5.0%	-17.3%	-14.2%
8/7/2025	0.0%	8.7%	20.8%
3/12/2025	-13.5%	-16.2%	-8.9%
11/7/2024	4.2%	-1.8%	5.7%
8/7/2024	6.1%	2.9%	4.6%
3/13/2024	-24.9%	-19.0%	-32.3%
11/8/2023	14.1%	26.4%	41.0%
8/9/2023	-10.1%	1.7%	0.9%
3/15/2023	4.2%	-15.9%	-2.7%
11/9/2022	-4.6%	-9.6%	-21.8%
8/10/2022	-21.3%	-11.1%	-11.6%
3/30/2022	14.9%	41.3%	103.7%
11/12/2021	0.2%	8.4%	4.8%
8/12/2021	-6.6%	-1.7%	54.8%
4/1/2021	-6.7%	-7.5%	-5.9%
11/10/2020	-0.7%	-1.4%	20.0%
8/10/2020	2.5%	11.9%	-11.3%
3/4/2020	5.5%	-15.2%	-45.1%
SUMMARY STATS
# Positive	9	7	9
# Negative	9	11	9
Median Positive	4.2%	8.7%	20.0%
Median Negative	-6.7%	-11.1%	-11.6%
Max Positive	14.9%	41.3%	103.7%
Max Negative	-24.9%	-19.0%	-45.1%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
9302025	11062025	10-Q 9/27/2025
6302025	8072025	10-Q 6/28/2025
3312025	5082025	10-Q 3/29/2025
12312024	3132025	10-K 12/28/2024
9302024	11072024	10-Q 9/28/2024
6302024	8082024	10-Q 6/29/2024
3312024	5092024	10-Q 3/30/2024
12312023	3142024	10-K 12/31/2023
9302023	11092023	10-Q 9/30/2023
6302023	8102023	10-Q 7/1/2023
3312023	5102023	10-Q 4/1/2023
12312022	3162023	10-K 12/31/2022
9302022	11102022	10-Q 10/1/2022
6302022	8112022	10-Q 7/2/2022
3312022	4282022	10-Q 4/2/2022
12312021	4042022	10-K 1/1/2022

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Vizi Bradley	Executive Chairman & President	9242025	Sell	27.50	1,165	32,038	41,564,215	Form
1	Vizi Bradley	Executive Chairman & President	9032025	Sell	27.50	673	18,508	42,110,145	Form
2	Vizi Bradley	Executive Chairman & President	8282025	Sell	27.51	7,289	200,520	42,143,972	Form
3	Saks Michael	Division President, HC Srvs.	8282025	Sell	27.50	5,000	137,500	3,012,542	Form
4	Saks Michael	Division President, HC Srvs.	3182025	Sell	15.89	300	4,767	1,813,939	Form

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

RCM Technologies (RCMT)

Market Price (12/24/2025): $20.28 | Market Cap: $150.3 MilSector: Industrials | Industry: Industrial Conglomerates

RCM Technologies (RCMT)

Market Price (12/24/2025): $20.28Market Cap: $150.3 MilSector: IndustrialsIndustry: Industrial Conglomerates

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

Valuation, Metrics & Events

RCMT Stock

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About RCM Technologies (RCMT)

Engineering Services

Specialty Healthcare Services

Life Sciences, Data & Solutions / Information Technology (IT) Services

Share Repurchases

Share Issuance

Outbound Investments

Capital Expenditures

Interactive Breakdown

Better Bets than RCM Technologies (RCMT)

INDUSTRY: Industrial Conglomerates

Higher Rev Chg 3Y Avg | Lower P/S (Values for RCMT: 3.8% | 0.5x)

Higher Rev Chg LTM (Value for RCMT: 13.7%)

Higher Rev Chg 3Y Avg (Value for RCMT: 3.8%)

Higher Op Mgn LTM (Value for RCMT: 7.2%)

Higher CFO/Rev LTM (Value for RCMT: 1.9%)

Higher FCF/Rev LTM (Value for RCMT: 1.1%)

Higher Total Yield (Value for RCMT: 8.7%)

SECTOR: Industrials

Higher Rev Chg 3Y Avg | Lower P/S (Values for RCMT: 3.8% | 0.5x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for RCMT: 3.8% | 6.8x)

Higher Rev Chg LTM (Value for RCMT: 13.7%)

Higher Rev Chg 3Y Avg (Value for RCMT: 3.8%)

Higher Op Mgn LTM (Value for RCMT: 7.2%)

Higher CFO/Rev LTM (Value for RCMT: 1.9%)

Higher FCF/Rev LTM (Value for RCMT: 1.1%)

Higher Total Yield (Value for RCMT: 8.7%)

All Other Sectors

Higher Rev Chg 3Y Avg | Lower P/S (Values for RCMT: 3.8% | 0.5x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for RCMT: 3.8% | 6.8x)

Higher Rev Chg LTM (Value for RCMT: 13.7%)

Higher Rev Chg 3Y Avg (Value for RCMT: 3.8%)

Higher Op Mgn LTM (Value for RCMT: 7.2%)

Higher CFO/Rev LTM (Value for RCMT: 1.9%)

Higher FCF/Rev LTM (Value for RCMT: 1.1%)

Higher Total Yield (Value for RCMT: 8.7%)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

Top Gainers

Top Losers

Top Gainers

Top Losers

Top Gainers

Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for RCM Technologies

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Market Price (12/24/2025): $20.28 | Market Cap: $150.3 Mil
Sector: Industrials | Industry: Industrial Conglomerates

Market Price (12/24/2025): $20.28
Market Cap: $150.3 Mil
Sector: Industrials
Industry: Industrial Conglomerates